Ranibizumab in patients with neovascular age-related macular degeneration: results from the real-world LUMINOUS™ study

被引：1
|
作者：
Souied, E. [1 ]
Clemens, A. [2 ]
Macfadden, W. [2 ]
机构：
[1] CHIC Creteil, Ophthalmol, Creteil, France
[2] Novartis Pharma AG, Basel, Switzerland
来源：
ACTA OPHTHALMOLOGICA | 2017年 / 95卷
关键词：
D O I：
10.1111/j.1755-3768.2017.01111
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] RANIBIZUMAB TREATMENT IN TREATMENT-NAIVE NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Results From LUMINOUS, a Global Real-World Study
    Holz, Frank G.
    Figueroa, Marta S.
    Bandello, Francesco
    Yang, Yit
    Ohji, Masahito
    Dai, Hong
    Wykrota, Halina
    Sharma, Sanjay
    Dunger-Baldauf, Cornelia
    Lacey, Sue
    Macfadden, Wayne
    Mitchell, Paul
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2020, 40 (09): : 1673 - 1685
  • [2] Outcomes at 1 Year with Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration: Real-World Results from the LUMINOUS Study
    Mitchell, Paul
    Macfadden, Wayne
    Lacey, Sue
    [J]. OPHTHALMOLOGICA, 2016, 236 : 1 - 1
  • [3] Ranibizumab treatment patterns in prior ranibizumab-treated neovascular age-related macular degeneration patients: Real-world outcomes from the LUMINOUS study
    Holz, Frank G.
    Minnella, Angelo M.
    Tuli, Raman
    Yoganathan, Pradeepa
    Parikh, Soumil
    Hamilton, Robin
    [J]. PLOS ONE, 2020, 15 (12):
  • [4] Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan
    Chang, Yi-Sheng
    Lee, Wan-Ju
    Lim, Chen-Chee
    Wang, Shih-Hao
    Hsu, Sheng-Min
    Chen, Yi-Chian
    Cheng, Chia-Yi
    Teng, Yu-Ti
    Huang, Yi-Hsun
    Lai, Chun-Chieh
    Tseng, Sung-Huei
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [5] Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan
    Yi-Sheng Chang
    Wan-Ju Lee
    Chen-Chee Lim
    Shih-Hao Wang
    Sheng-Min Hsu
    Yi-Chian Chen
    Chia-Yi Cheng
    Yu-Ti Teng
    Yi-Hsun Huang
    Chun-Chieh Lai
    Sung-Huei Tseng
    [J]. Scientific Reports, 8
  • [6] Real-World Effectiveness, Treatment Pattern, and Safety of Ranibizumab in Korean Patients with Neovascular Age-Related Macular Degeneration: Subgroup Analyses from the LUMINOUS Study
    Sagong, Min
    Woo, Se Joon
    Lee, Youkyung
    [J]. CLINICAL OPHTHALMOLOGY, 2021, 15 : 1995 - 2011
  • [7] Ranibizumab in patients with neovascular age-related macular degeneration in real-world clinical settings in France: 1-year data from the LUMINOUS™ study
    Capuano, Vittorio
    Oubraham-Mebroukine, Hassiba
    Wolff, Benjamin
    Cohen, Salomon Y.
    Garcher, Catherine P.
    Korobelnik, Jean-Francois
    Tadayoni, Ramin
    Delhay, Christian
    Derveloy, Audrey
    Souied, Eric H.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [8] Long-Term Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Belgian Subanalysis from the Global Real-World LUMINOUS™ Study
    Leys, Anita M.
    Ramboer, Eva
    Favreau, Meredis
    Denhaerynck, Kris
    MacDonald, Karen
    Abraham, Ivo
    Brie, Heidi
    [J]. CLINICAL OPHTHALMOLOGY, 2020, 14 : 1473 - 1481
  • [9] METAANALYSIS OF REAL-WORLD OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Kim, Leah N.
    Mehta, Hemal
    Barthelmes, Daniel
    Vuong Nguyen
    Gillies, Mark C.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (08): : 1418 - 1431
  • [10] RANIBIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN A REAL WORLD CLINICAL SETTING
    Abell, Robin
    Lim, Diane
    Kerr, Nathan
    Allen, Penelope
    Vote, Brendan
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 40 : 103 - 104
12345